We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.66B
AUM Growth
Cap. Flow
+$5.62B
Cap. Flow %
99.29%
Top 10 Hldgs %
12.49%
Holding
959
New
959
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$135M
2
XOM icon
ExxonMobil
XOM
+$90.4M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$88.8M
4
MSFT icon
Microsoft
MSFT
+$67.3M
5
WMT icon
Walmart Inc
WMT
+$59.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 18.54%
2 Industrials 12.9%
3 Financials 11.08%
4 Consumer Discretionary 10.68%
5 Healthcare 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RICK icon
926
RCI Hospitality Holdings
RICK
$199M
$131K ﹤0.01%
+15,150
New +$130K
ARC
927
DELISTED
ARC Document Solutions, Inc.
ARC
$120K ﹤0.01%
+29,900
New +$103K
ONCT
928
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$119K ﹤0.01%
+13
New +$100K
LOCM
929
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$118K ﹤0.01%
+70,093
New +$119K
MCBI
930
DELISTED
METROCORP BANCSHARES INC
MCBI
$118K ﹤0.01%
+12,127
New +$122K
TTGT icon
931
TechTarget
TTGT
$246M
$114K ﹤0.01%
+25,456
New +$112K
HHS icon
932
Harte-Hanks
HHS
$110K ﹤0.01%
+1,280
New +$106K
BCRX icon
933
BioCryst Pharmaceuticals
BCRX
$2.37B
$109K ﹤0.01%
+70,400
New +$121K
ACHV icon
934
Achieve Life Sciences
ACHV
$626M
$105K ﹤0.01%
+5
New +$112K
MAXY
935
DELISTED
MAXYGEN INC
MAXY
$104K ﹤0.01%
+41,801
New +$101K
OMN
936
DELISTED
OMNOVA Solutions Inc.
OMN
$93K ﹤0.01%
+11,636
New +$84.8K
ULBI icon
937
Ultralife
ULBI
$88.3M
$90K ﹤0.01%
+25,261
New +$98.6K
OSPN icon
938
OneSpan
OSPN
$562M
$89K ﹤0.01%
+10,694
New +$89.8K
LFVN icon
939
LifeVantage
LFVN
$82.4M
$88K ﹤0.01%
+5,400
New +$86.7K
QUMU
940
DELISTED
Qumu Corp.
QUMU
$84K ﹤0.01%
+10,132
New +$85.1K
ALBO
941
DELISTED
Albireo Pharma Inc
ALBO
$83K ﹤0.01%
+659
New +$68.6K
GSE
942
DELISTED
GSE HLDG INC COM STK (DE)
GSE
$82K ﹤0.01%
+14,112
New +$97.2K
BDSI
943
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$82K ﹤0.01%
+20,100
New +$94.3K
TAST
944
DELISTED
Carrols Restaurant Group, Inc.
TAST
$79K ﹤0.01%
+12,300
New +$68.6K
NAUH
945
DELISTED
National American University Holdings, Inc.
NAUH
$74K ﹤0.01%
+19,840
New +$70.2K
LCAV
946
DELISTED
LCA-VISION INC
LCAV
$73K ﹤0.01%
+24,100
New +$78.6K
EPAX
947
DELISTED
Ambassadors Group Inc
EPAX
$71K ﹤0.01%
+20,081
New +$73.3K
ABR icon
948
Arbor Realty Trust
ABR
$960M
$70K ﹤0.01%
+11,100
New +$79.5K
CRD.B icon
949
Crawford & Co Class B
CRD.B
$493M
$64K ﹤0.01%
+11,322
New +$79.8K
JRCC
950
DELISTED
JAMES RIVER COAL NEW
JRCC
$62K ﹤0.01%
+34,100
New +$73.5K

Similar funds

Jacobs Levy Equity Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jacobs Levy Equity Management, which disclosed 959 positions worth $5.66B. Its ten largest holdings account for 12% of the portfolio.

Its largest position is Apple: 8,755,796 shares worth $124M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, followed by Industrials and Financials.

  • Jacobs Levy Equity Management's largest Q2 2013 buy was Apple: 8,755,796 shares worth $124M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.66B portfolio in Q2 2013.
  • Jacobs Levy Equity Management disclosed 959 positions in Q2 2013, its first 13F filing on record.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2013, filed 14 Aug 2013.